Albumin infusion rate and plasma volume expansion: a randomized clinical trial in postoperative patients after major surgery

Abstract Background Optimal infusion rate of colloids in patients with suspected hypovolemia is unknown, and the primary objective of the present study was to test if plasma volume expansion by 5% albumin is greater if fluid is administered slowly rather than rapidly. Methods Patients with signs of...

Full description

Bibliographic Details
Main Authors: Svajunas Statkevicius, Johan Bonnevier, Jane Fisher, Björn P. Bark, Erik Larsson, Carl M. Öberg, Päivi Kannisto, Bobby Tingstedt, Peter Bentzer
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Critical Care
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13054-019-2477-7
id doaj-c50fd862dc46417d929c44dee43b920b
record_format Article
spelling doaj-c50fd862dc46417d929c44dee43b920b2020-11-25T03:17:55ZengBMCCritical Care1364-85352019-05-0123111010.1186/s13054-019-2477-7Albumin infusion rate and plasma volume expansion: a randomized clinical trial in postoperative patients after major surgerySvajunas Statkevicius0Johan Bonnevier1Jane Fisher2Björn P. Bark3Erik Larsson4Carl M. Öberg5Päivi Kannisto6Bobby Tingstedt7Peter Bentzer8Department of Anesthesia & Intensive Care, Skåne University HospitalDepartment of Anesthesia & Intensive Care, Skåne University HospitalDepartment of Infectious Diseases, Skåne University HospitalDepartment of Anesthesia & Intensive Care, Skåne University HospitalDepartment of Radiation Physics, Skåne University HospitalDepartment of Nephrology, Skåne University HospitalDepartment of Gynecology and Obstetrics, Skåne University HospitalDepartment of Surgery, Skåne University HospitalDepartment of Anesthesia and Intensive Care, Helsingborg Hospital, Helsingborg and Lund UniversityAbstract Background Optimal infusion rate of colloids in patients with suspected hypovolemia is unknown, and the primary objective of the present study was to test if plasma volume expansion by 5% albumin is greater if fluid is administered slowly rather than rapidly. Methods Patients with signs of hypoperfusion after major abdominal surgery were randomized to intravenous infusion of 5% albumin at a dose of 10 ml/kg (ideal body weight) either rapidly (30 min) or slowly (180 min). Plasma volume was measured using radiolabeled albumin at baseline, at 30 min, and at 180 min after the start of infusion. Primary outcome was change in plasma volume from the start of infusion to 180 min after the start of infusion. Secondary outcomes included the change in the area under the plasma volume curve and transcapillary escape rate (TER) for albumin from 180 to 240 min after the start of albumin infusion. Results A total of 33 and 31 patients were included in the analysis in the slow and rapid groups, respectively. The change in plasma volume from the start of infusion to 180 min did not differ between the slow and rapid infusion groups (7.4 ± 2.6 vs. 6.5 ± 4.1 ml/kg; absolute difference, 0.9 ml/kg [95%CI, − 0.8 to 2.6], P = 0.301). Change in the area under the plasma volume curve was smaller in the slow than in the rapid infusion group and was 866 ± 341 and 1226 ± 419 min ml/kg, respectively, P < 0.001. TER for albumin did not differ and was 5.3 ± 3.1%/h and 5.4 ± 3%/h in the slow and in the rapid infusion groups, respectively, P = 0.931. Conclusions This study does not support our hypothesis that a slow infusion of colloid results in a greater plasma volume expansion than a rapid infusion. Instead, our result of a smaller change in the area under the plasma volume curve indicates that a slow infusion results in a less efficient plasma volume expansion, but further studies are required to confirm this finding. A rapid infusion has no effect on vascular leak as measured after completion of the infusion. Trial registration EudraCT2013-004446-42 registered December 23, 2014.http://link.springer.com/article/10.1186/s13054-019-2477-7Plasma volume expandersFluid therapySerum albumin
collection DOAJ
language English
format Article
sources DOAJ
author Svajunas Statkevicius
Johan Bonnevier
Jane Fisher
Björn P. Bark
Erik Larsson
Carl M. Öberg
Päivi Kannisto
Bobby Tingstedt
Peter Bentzer
spellingShingle Svajunas Statkevicius
Johan Bonnevier
Jane Fisher
Björn P. Bark
Erik Larsson
Carl M. Öberg
Päivi Kannisto
Bobby Tingstedt
Peter Bentzer
Albumin infusion rate and plasma volume expansion: a randomized clinical trial in postoperative patients after major surgery
Critical Care
Plasma volume expanders
Fluid therapy
Serum albumin
author_facet Svajunas Statkevicius
Johan Bonnevier
Jane Fisher
Björn P. Bark
Erik Larsson
Carl M. Öberg
Päivi Kannisto
Bobby Tingstedt
Peter Bentzer
author_sort Svajunas Statkevicius
title Albumin infusion rate and plasma volume expansion: a randomized clinical trial in postoperative patients after major surgery
title_short Albumin infusion rate and plasma volume expansion: a randomized clinical trial in postoperative patients after major surgery
title_full Albumin infusion rate and plasma volume expansion: a randomized clinical trial in postoperative patients after major surgery
title_fullStr Albumin infusion rate and plasma volume expansion: a randomized clinical trial in postoperative patients after major surgery
title_full_unstemmed Albumin infusion rate and plasma volume expansion: a randomized clinical trial in postoperative patients after major surgery
title_sort albumin infusion rate and plasma volume expansion: a randomized clinical trial in postoperative patients after major surgery
publisher BMC
series Critical Care
issn 1364-8535
publishDate 2019-05-01
description Abstract Background Optimal infusion rate of colloids in patients with suspected hypovolemia is unknown, and the primary objective of the present study was to test if plasma volume expansion by 5% albumin is greater if fluid is administered slowly rather than rapidly. Methods Patients with signs of hypoperfusion after major abdominal surgery were randomized to intravenous infusion of 5% albumin at a dose of 10 ml/kg (ideal body weight) either rapidly (30 min) or slowly (180 min). Plasma volume was measured using radiolabeled albumin at baseline, at 30 min, and at 180 min after the start of infusion. Primary outcome was change in plasma volume from the start of infusion to 180 min after the start of infusion. Secondary outcomes included the change in the area under the plasma volume curve and transcapillary escape rate (TER) for albumin from 180 to 240 min after the start of albumin infusion. Results A total of 33 and 31 patients were included in the analysis in the slow and rapid groups, respectively. The change in plasma volume from the start of infusion to 180 min did not differ between the slow and rapid infusion groups (7.4 ± 2.6 vs. 6.5 ± 4.1 ml/kg; absolute difference, 0.9 ml/kg [95%CI, − 0.8 to 2.6], P = 0.301). Change in the area under the plasma volume curve was smaller in the slow than in the rapid infusion group and was 866 ± 341 and 1226 ± 419 min ml/kg, respectively, P < 0.001. TER for albumin did not differ and was 5.3 ± 3.1%/h and 5.4 ± 3%/h in the slow and in the rapid infusion groups, respectively, P = 0.931. Conclusions This study does not support our hypothesis that a slow infusion of colloid results in a greater plasma volume expansion than a rapid infusion. Instead, our result of a smaller change in the area under the plasma volume curve indicates that a slow infusion results in a less efficient plasma volume expansion, but further studies are required to confirm this finding. A rapid infusion has no effect on vascular leak as measured after completion of the infusion. Trial registration EudraCT2013-004446-42 registered December 23, 2014.
topic Plasma volume expanders
Fluid therapy
Serum albumin
url http://link.springer.com/article/10.1186/s13054-019-2477-7
work_keys_str_mv AT svajunasstatkevicius albumininfusionrateandplasmavolumeexpansionarandomizedclinicaltrialinpostoperativepatientsaftermajorsurgery
AT johanbonnevier albumininfusionrateandplasmavolumeexpansionarandomizedclinicaltrialinpostoperativepatientsaftermajorsurgery
AT janefisher albumininfusionrateandplasmavolumeexpansionarandomizedclinicaltrialinpostoperativepatientsaftermajorsurgery
AT bjornpbark albumininfusionrateandplasmavolumeexpansionarandomizedclinicaltrialinpostoperativepatientsaftermajorsurgery
AT eriklarsson albumininfusionrateandplasmavolumeexpansionarandomizedclinicaltrialinpostoperativepatientsaftermajorsurgery
AT carlmoberg albumininfusionrateandplasmavolumeexpansionarandomizedclinicaltrialinpostoperativepatientsaftermajorsurgery
AT paivikannisto albumininfusionrateandplasmavolumeexpansionarandomizedclinicaltrialinpostoperativepatientsaftermajorsurgery
AT bobbytingstedt albumininfusionrateandplasmavolumeexpansionarandomizedclinicaltrialinpostoperativepatientsaftermajorsurgery
AT peterbentzer albumininfusionrateandplasmavolumeexpansionarandomizedclinicaltrialinpostoperativepatientsaftermajorsurgery
_version_ 1724629048736350208